Eukaryotic mRNA decay
Team Leader : Bertrand SERAPHIN
Department : Executive management
SUBGROUP LEADER
While the main mRNA decay pathway involves the 5’ to 3’ degradation of the mRNA body, 3’ to 5’ exonucleolytic mRNA trimming has been shown to play a major role for the elimination of defective, poorly translatable transcripts. Factors involved in the latter pathway are altered in a rare human genetic disease, underlining its importance. In this context, we are testing the role of these factors in pathological conditions. Moreover, we have identified new factors associated with 3’-5’ mRNA decay and are actively pursuing their characterization.
Article in a journal
Cell Reports ; Volume: 6 ; Page: 593--598
Article in a journal
EMBO Journal ; Volume: 33 ; Page: 265-276
Article in a journal
Nucleic Acids Research ; Volume: 42 ; Page: 12847-12860
Article in a journal
Journal of Biological Chemistry ; Volume: 289 ; Page: 28640-28650
Article in a journal
Nucleic Acids Research ; Volume: 41 ; Page: 9514-9523
Article in a journal
FEBS Journal ; Volume: 280 ; Page: 2712-2726
Article in a journal
Nature Structural and Molecular Biology ; Volume: 20 ; Page: 1281-1288
Article in a journal
BBA - Biochimica et Biophysica Acta ; Volume: 1829 ; Page: 491-513
Article in a journal
RNA Biology ; Volume: 10 ; Page: 267-276
Article in a journal
Molecular Cell ; Volume: 48 ; Page: 409-21
Page 3 of 5